Consensus guideline

Radiation therapy and hearing loss (QUANTEC)

Bhandare N, Jackson A, Eisbruch A, et al. · QUANTEC

View Source Under Review

DoseLab summary

The hearing-loss chapter of the 2010 QUANTEC supplement. Citation checked against Crossref; content not yet reviewed by DoseLab.

Why this is useful

The QUANTEC hearing chapter: cochlear dose and the risk of sensorineural hearing loss, including the effect of cisplatin.

Reference details

Title
Radiation therapy and hearing loss (QUANTEC)
Authors / organization
Bhandare N, Jackson A, Eisbruch A, et al. · QUANTEC
Publication / protocol
Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S50–S57
Version
Pending verification
Year
2010
DOI
10.1016/j.ijrobp.2009.04.096
Disease sites
Head & Neck, CNS / Brain
Topics
Dose Constraints, QUANTEC, Cochlea, Hearing, Conventional fractionation
Fractionation context
Conventional fractionation
Last reviewed by DoseLab
Pending verification

Cited on DoseLab